Today on DrugResearcher.com   Bayer pipeline in good shape as merger rumours build Amgen's approach to selectivity predictions UK tightens Phase I guidelines Applied Biosystems expanding genotyping access

Related Industry News   First ever once-a-year osteoporosis drug approved Revamped Wyeth drug gets EU go-ahead Biopartners files MS drug in Europe Pharmatek bows to cytotoxic trend

Breaking News on Drug Discovery
Daily  Tuesday 21 August 2007		Forward to a colleague

	Product Overview Pre-Clinical Contract Research - Free Download Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories Bayer pipeline in good shape as merger rumours build Analysts believe Bayer's research and development pipeline is well equipped to deal with looming patent expiries but that didn't stop rumours of a Novartis buyout last week... Read Amgen's approach to selectivity predictions Amgen has outlined how it uses computer models to predict the selectivity of small molecule drugs... Read UK tightens Phase I guidelines The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK... Read Applied Biosystems expanding genotyping access Through a new service partnership, Applied Biosystems is helping scientists study genetic variations - even if they can't access or afford the necessary lab equipment... Read
	All News Headlines for: August | July | June
	Technical / White paper deltaDOT label free analysis of biomolecules Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
	Related Industry News First ever once-a-year osteoporosis drug approved Swiss firm Novartis has gained US approval of its once-yearly treatment for postmenopausal osteoporosis, with EU approval expected to follow hot on its heels... Read Revamped Wyeth drug gets EU go-ahead An improved version of Wyeth's haemophilia B treatment BeneFix - the only recombinant Factor IX product available on the market - kitted out with a host of new user-friendly features, has been approved in the EU... Read Biopartners files MS drug in Europe Biopartners has filed for approval of a new version of interferon beta-1a in the EU, laying down a challenge to rival manufacturers of multiple sclerosis drugs... Read Pharmatek bows to cytotoxic trend Pharmatek Laboratories has now added cytotoxic and high-potent drug development services to its list of contract pharmaceutical offerings... Read Weekly comment Speculation on gene therapy trial death 'premature' Targeted Genetics said it was 'premature as well as irresponsible' to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm's new gene therapy. Read Previous Headlines Amgen admits job cuts on way after anaemia drugs drama Amgen has finally put an end to weeks of rumours and speculations by admitting its plans to slash 12-14 per cent of its workforce to offset the recent difficulties it has been facing with the sales of its anaemia... Read Blockbuster potential for Actelion insomnia drug Analysts are waiting with baited breath for the latest clinical data on Actelion's first-in-class insomnia drug, pointing to its blockbuster potential and deriding current insomnia drugs as 'shockingly limited'... Read Did Pfizer overpay in Icagen deal? Pfizer has penned a discovery-stage deal with Icagen aimed at finding potential pain alleviating drugs, but has forked out over twice the industry average... Read Agilent expands microarray offering with FFPE sample labelling kit Using technology recently licensed from Kreatech, Agilent has launched a kit to enable researchers to more easily access genetic information from formalin-fixed paraffin embedded (FFPE) samples... Read DNA vaccine for MS passes Phase I A new DNA vaccine has passed a Phase I trial in patients with multiple sclerosis (MS) and is set to enter the next development stage, according to researchers... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com